7-Hydroxyquinolinone CAS 70500-72-0 Puritas > 98.0% (HPLC)

Description:

Nomen chemicum: 7-Hydroxyquinolinone

Synonyma: 2,7-Dihydroxyquinolina

CAS: 70500-72-0

Puritas: >98.0% (HPLC)

Aspectus: Alba ad Yellow Firmus

Medium Brexpiprazole (CAS: 913611-97-9)

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Chemical Properties:

Nomen chemicum 7-Hydroxyquinolinone
Synonyma 2,7-Dihydroxyquinoline;7-Hydroxy-1,2-Dihydroquinolin-2-unum;7-Hydroxyquinolin-2(1H)-one;3,4-Dihydro-7-Hydroxycarbostylil;7-Hydroxycarbostyril
CAS Number 70500-72-0
CATTUS Number RF-PI1979
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C9H7NO2
M. Pondus 161.16
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Alba ad Yellow Firmus
Puritas / Analysis Methodus >98.0% (HPLC)
Infrared Imaginis Conformat ut Structure
Proton NMR Spectrum Conformat ut Structure
Damnum in Siccatio <1.00%
Metalla gravis <0.002%
Totalis immunditias <2.0%
Fasciae vita Annis II
Test Standard Enterprise Standard
Consuetudinem Medium Brexpiprazole (CAS: 913611-97-9)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

1

FAQ:

Applicatio:

7-Hydroxyquinolinone (CAS: 70500-72-0) substituitur carbostyrilis derivativis pharmaceuticae intermedii.7-Hydroxyquinolinone media est Brexpiprazolis (CAS: 913611-97-9).Brexpiprazole medicamentum est candidatus utilis in curatione et praecavatione perturbationum mentalium inclusorum CN perturbationes.Brexpiprazole est genus atypicum antipsychoticum.Est dopamine D2 receptor partialis agonist.Cum nova actio modulatoris serotonin-dopamine, Brexpiprazole adhiberi potest ad schizophreniae tractationem et ad adiunctivam curationem pro tristitia.Brexpiprazole etiam efficaciam et tolerabilitatem in curationibus adiunctivis statutis inordinationis depressivae (MDD).Recentes studium etiam Brexpiprazole suggessit posse meliorare PCP defectus cognitivas in muribus per receptores 5-HT1A inductos.

Epistulam tuam hic scribe et mitte nobis